These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3489716)

  • 1. A comparison of combined diphtheria, tetanus and pertussis vaccines produced by different manufacturers, in laboratory animals and in infants.
    Nyerges G; Adám MM; Gács P; Ring R
    J Biol Stand; 1986 Jul; 14(3):241-7. PubMed ID: 3489716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reduction of animal usage by the application of indirect haemagglutination in the potency testing of diphtheria toxoid in combined vaccines.
    Maheshwari SC; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1988 Jan; 16(1):9-14. PubMed ID: 3258309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasible improvements in vaccines in the Expanded Programme on Immunization.
    McIntosh K
    Rev Infect Dis; 1989; 11 Suppl 3():S530-7. PubMed ID: 2669097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the minimal number of animals required to achieve assurance of satisfactory potency in diphtheria and tetanus vaccines.
    Knight PA; Roberts PA
    Dev Biol Stand; 1986; 65():245-53. PubMed ID: 3493931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a mouse model to estimate the potency of the diphtheria toxoid component of diphtheria-tetanus and diphtheria-tetanus-pertussis vaccines.
    Maheshwari SC; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1988 Jul; 16(3):139-46. PubMed ID: 3170614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of infants to Haemophilus influenzae type b polysaccharide and diphtheria-tetanus-pertussis vaccines in combination.
    Lepow ML; Peter G; Glode MP; Daum RS; Calnen G; Knight KM; Mayer D; Kuo JS; Lui NS
    J Infect Dis; 1984 Jun; 149(6):950-5. PubMed ID: 6376656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report of an informal meeting about alternative methods for the potency control of the diphtheria and tetanus components in vaccines.
    Kreeftenberg JG
    Dev Biol Stand; 1986; 65():261-6. PubMed ID: 3493932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of preterm infants to diphtheria-tetanus-pertussis immunizations.
    Bernbaum JC; Daft A; Anolik R; Samuelson J; Barkin R; Douglas S; Polin R
    J Pediatr; 1985 Aug; 107(2):184-8. PubMed ID: 3874942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetaminophen prophylaxis of adverse reactions following vaccination of infants with diphtheria-pertussis-tetanus toxoids-polio vaccine.
    Ipp MM; Gold R; Greenberg S; Goldbach M; Kupfert BB; Lloyd DD; Maresky DC; Saunders N; Wise SA
    Pediatr Infect Dis J; 1987 Aug; 6(8):721-5. PubMed ID: 3313232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactions to DTP and DT vaccines.
    Med J Aust; 1983 Apr; 1(9):405-6. PubMed ID: 6601229
    [No Abstract]   [Full Text] [Related]  

  • 12. [Criteria for the assessment of the reactogenicity of ADPT vaccine].
    Zakharova MS; Novikova OM; Selidovkin DS; Kokina VIa; Lebedeva VI
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jun; 50(6):44-9. PubMed ID: 4780911
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-vaccination symptoms following DTP and DT vaccination.
    Pollock TM; Miller E; Mortimer JY; Smith G
    Dev Biol Stand; 1985; 61():407-10. PubMed ID: 3879685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An antibody induction method in mice for the potency assays of diphtheria and tetanus components in combined vaccines.
    Maheshwari SC; Sharma SB; Kumar A; Sokhey J
    J Commun Dis; 1998 Sep; 30(3):139-46. PubMed ID: 10093418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis vs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18- to 24-month old children.
    Pichichero ME; Badgett JT; Rodgers GC; McLinn S; Trevino-Scatterday B; Nelson JD
    Pediatr Infect Dis J; 1987 Apr; 6(4):352-63. PubMed ID: 3495775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diphtheria, pertussis, and tetanus (DTP) immunization local reactions do not predict central nervous system reactions.
    Blattner RJ; Feigin RD
    Pediatrics; 1986 Dec; 78(6):1168-9. PubMed ID: 3491358
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulating immune complexes after DTP vaccination.
    Wilkins J
    J Pediatr; 1987 Jul; 111(1):162. PubMed ID: 3496441
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccination and cot deaths in perspective.
    Roberts SC
    Arch Dis Child; 1987 Jul; 62(7):754-9. PubMed ID: 3498443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The determination of the protective potency of the diphtheria component in combined vaccines by the indirect hemagglutination (IHA) method].
    Unver SD; Ozcengiz E
    Mikrobiyol Bul; 1990 Oct; 24(4):327-35. PubMed ID: 2287290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DTP vaccine litigation.
    Hinman AR
    Am J Dis Child; 1986 Jun; 140(6):528-30. PubMed ID: 3486586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.